The Healthcare Leadership Council (HLC) submits comments to the U.S. Department of Commerce regarding the Section 232 national security investigation into imports of PPE, medical consumables, medical equipment, and medical devices. HLC aims to highlight how trade actions could affect patient access, innovation, and the healthcare supply chain.
To The Administration
HLC response to Section 232 National Security Investigation of imports of PPE, medical consumables, and medical equipment
- Topics: Deregulation, Innovation, Patient Safety and Quality
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To The Administration
Group letter to DOL on advancing the “Electronic Disclosure by Group Health Plans Under ERISA” proposed rule
Stakeholders representing employers, businesses, and environmental organizations urged the Department of Labor (DOL) to finalize its proposal to permit default electronic delivery (e-delivery) for group health plan communications under the Employee …
To Congress
Group letter urging House leadership to advance H.R. 2332/S.1101, the “SHARE Act”
HLC joined the Interstate Healthcare Collaborative and other healthcare organizations in urging House leadership to advance the bipartisan States Handling Access to Reciprocity for Employment (SHARE) Act (H.R. 2332/S. 1101). The legislation would ad…
To The Administration
Group letter to CMS opposing proposed remote monitoring restrictions in the 2027 Physician Fee Schedule
HLC also joined a coalition letter urging CMS not to finalize proposed changes to remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) in the 2027 Physician Fee Schedule proposed rule that would restrict clinically integrated …
